July 1, 2020 / 5:06 AM / 7 days ago

BRIEF-Obseva And Yuyuan Bioscience Technology Submit Pre-Ind Dossier For Nolasiban With Chinese NMPA

July 1 (Reuters) - Obseva SA:

* OBSEVA AND YUYUAN BIOSCIENCE TECHNOLOGY ANNOUNCE SUBMISSION OF PRE-IND DOSSIER FOR NOLASIBAN WITH CHINESE NMPA

* YUYUAN HAS SUBMITTED A PRE-IND MEETING REQUEST FOR NOLASIBAN TO CENTER FOR DRUG EVALUATION AT CHINESE NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below